Gilead Sciences drug lenacapavir, brand name Yeztugo, is now approved for HIV pre-exposure prophylaxis. The twice injectable medication is hoped to improve uptake and adherence to PrEP. The post Gilead Sciences Lands First FDA Approval of a Twice-a-Year HIV PrEP Drug appeared first on MedCity News.
Phase 3 results for the Novartis malaria drug “GanLum” show it was comparable to the standard of care and led to cure rates that top the threshold recommended by the World Health Organization. If approved, this new combination drug would become the first novel malaria therapy in more than 25 years. The post Novel Novartis…
This volume explores findings from the KFF-Washington Post Survey of Parents on views of childhood vaccines; how ACIP may have contributed to concerns about hepatitis B and COVID-19 vaccines; recent HHS warnings about alleged links between Tylenol use in pregnancy and autism; and AI-generated deepfakes impersonating doctors to sell products.
Californians in November will weigh in on a ballot initiative to increase scrutiny over the use of health-care dollars — particularly money from a federal drug discount program — meant to support patient care largely for low-income or indigent people. The revenue is sometimes used to address housing instability and homelessness among vulnerable patient populations. Voters…
Hospitals’ costs are climbing steadily — driven by chronic underpayments from payers, growing administrative requirements and increasing labor costs, according to a new report from the American Hospital Association. The post Hospitals’ Costs Are Soaring: 3 Stats to Know appeared first on MedCity News.
A former Mayo Clinic research director claims she was silenced, demoted and ultimately fired for sounding the alarm on AI safety and patient privacy lapses at the health system. Traci Tamiko Eto is now suing Mayo for retaliation. The post Former Mayo Clinic Leader Sues System Over Alleged AI Cover-Up: 6 Things to Know appeared…
This policy watch examines the burden of medical debt in North Carolina and the state’s new plan to leverage the Medicaid program to provide debt relief and support access to care for low-income North Carolinians.
This analysis looks at the individual market enrollees who make at least four times the federal poverty level who would no longer be eligible for any tax credits if the current ACA Marketplace enhanced subsidies expire at the end of this year. Compared to other people with similar incomes, these enrollees are more likely to…
Dr. Monarez is the agency’s current acting director
Improved automation and data-driven solutions are optimizing the patient collections process, even as providers face rising costs, shrinking reimbursements, looming changes to credit reporting, and an ongoing push toward greater efficiency. How do current solutions stack up against these challenges? Matt Hanas, Lead Product Manager at Experian Health, shares responses to some of the questions…